China Point-of-Care Diagnostics for Diabetes Industry Market Research Report 2023-2029

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the Point-of-Care Diagnostics for Diabetes industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • ACON Laboratories

    • Nova Biomedical

    • EKF Diagnostics

    • Nipro

    • Abbott

    • Prodigy Diabetes Care, LLC

    • F Hoffmann-La Roche Ltd

    • PlatInium Equity Advisors, LLC (Lifescan, Inc)

    • Bayer AG/Ascensia Diabetes Care Holdings AG

    By Type:

    • Type 2 Diabetes

    • Gestational Diabetes

    • Type 1 Diabetes

    By Application:

    • Hospitals and Diagnostic Laboratories

    • Homecare

    • Academic and Research Centers

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Point-of-Care Diagnostics for Diabetes Market Overview 2018-2029

    • 1.1 China Point-of-Care Diagnostics for Diabetes Industry Development Overview

    • 1.2 China Point-of-Care Diagnostics for Diabetes Industry Development History

    • 1.3 China Point-of-Care Diagnostics for Diabetes Industry Market Size (2018-2029)

    • 1.4 China Point-of-Care Diagnostics for Diabetes Market Analysis by Type from Production Side

      • 1.4.1 China Point-of-Care Diagnostics for Diabetes Production Volume, Production Value and Growth Rate of Type 2 Diabetes (2018-2029)

      • 1.4.2 China Point-of-Care Diagnostics for Diabetes Production Volume, Production Value and Growth Rate of Gestational Diabetes (2018-2029)

      • 1.4.3 China Point-of-Care Diagnostics for Diabetes Production Volume, Production Value and Growth Rate of Type 1 Diabetes (2018-2029)

    • 1.5 China Point-of-Care Diagnostics for Diabetes Market Analysis by Application from Consumption End

      • 1.5.1 China Point-of-Care Diagnostics for Diabetes Sales Volume, Sales Value and Growth Rate of Hospitals and Diagnostic Laboratories (2018-2029)

      • 1.5.2 China Point-of-Care Diagnostics for Diabetes Sales Volume, Sales Value and Growth Rate of Homecare (2018-2029)

      • 1.5.3 China Point-of-Care Diagnostics for Diabetes Sales Volume, Sales Value and Growth Rate of Academic and Research Centers (2018-2029)

    • 1.6 China Point-of-Care Diagnostics for Diabetes Market Analysis by Region

      • 1.6.1 North China Point-of-Care Diagnostics for Diabetes Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Point-of-Care Diagnostics for Diabetes Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Point-of-Care Diagnostics for Diabetes Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Point-of-Care Diagnostics for Diabetes Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Point-of-Care Diagnostics for Diabetes Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Point-of-Care Diagnostics for Diabetes Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Point-of-Care Diagnostics for Diabetes Market Size and Growth Rate from 2018-2029

    Chapter 2 China Point-of-Care Diagnostics for Diabetes Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Point-of-Care Diagnostics for Diabetes Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Point-of-Care Diagnostics for Diabetes Market Status and Competition Analysis in 2023

      • 2.2.3 China Point-of-Care Diagnostics for Diabetes Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Point-of-Care Diagnostics for Diabetes Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Point-of-Care Diagnostics for Diabetes Industry Development

    Chapter 3 Point-of-Care Diagnostics for DiabetesIndustry Chain Analysis

    • 3.1 Point-of-Care Diagnostics for Diabetes Industry Chain

    • 3.2 Point-of-Care Diagnostics for Diabetes Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Point-of-Care Diagnostics for Diabetes Market

    • 3.3 Point-of-Care Diagnostics for Diabetes Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Point-of-Care Diagnostics for Diabetes Market

    Chapter 4 China Point-of-Care Diagnostics for Diabetes Market, by Type

    • 4.1 China Point-of-Care Diagnostics for Diabetes Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Point-of-Care Diagnostics for Diabetes Total Production Volume and Growth Rate from Production Side

    • 4.5 China Point-of-Care Diagnostics for Diabetes Production Volume and Growth Rate, by Type

      • 4.5.1 China Point-of-Care Diagnostics for Diabetes Production Volume and Growth Rate of Type 2 Diabetes

      • 4.5.2 China Point-of-Care Diagnostics for Diabetes Production Volume and Growth Rate of Gestational Diabetes

      • 4.5.3 China Point-of-Care Diagnostics for Diabetes Production Volume and Growth Rate of Type 1 Diabetes

    Chapter 5 China Point-of-Care Diagnostics for Diabetes Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Point-of-Care Diagnostics for Diabetes Total Market Size and Growth Rate from Consumption End

    • 5.5 China Point-of-Care Diagnostics for Diabetes Market Size and Growth Rate, by Application

      • 5.5.1 China Point-of-Care Diagnostics for Diabetes Market Size and Growth Rate of Hospitals and Diagnostic Laboratories

      • 5.5.2 China Point-of-Care Diagnostics for Diabetes Market Size and Growth Rate of Homecare

      • 5.5.3 China Point-of-Care Diagnostics for Diabetes Market Size and Growth Rate of Academic and Research Centers

    Chapter 6 China Point-of-Care Diagnostics for Diabetes Market, by Region

    • 6.1 China Point-of-Care Diagnostics for Diabetes Production Volume and Production Value, by Region

    • 6.2 China Point-of-Care Diagnostics for Diabetes Sales Volume and Sales Value, by Region

    Chapter 7 North China Point-of-Care Diagnostics for Diabetes Market Analysis

    • 7.1 North China Point-of-Care Diagnostics for Diabetes Market, by Type

    • 7.2 North China Point-of-Care Diagnostics for Diabetes Market, by Application

    Chapter 8 Central China Point-of-Care Diagnostics for Diabetes Market Analysis

    • 8.1 Central China Point-of-Care Diagnostics for Diabetes Market, by Type

    • 8.2 Central China Point-of-Care Diagnostics for Diabetes Market, by Application

    Chapter 9 South China Point-of-Care Diagnostics for Diabetes Market Analysis

    • 9.1 South China Point-of-Care Diagnostics for Diabetes Market, by Type

    • 9.2 South China Point-of-Care Diagnostics for Diabetes Market, by Application

    Chapter 10 East China Point-of-Care Diagnostics for Diabetes Market Analysis

    • 10.1 East China Point-of-Care Diagnostics for Diabetes Market, by Type

    • 10.2 East China Point-of-Care Diagnostics for Diabetes Market, by Application

    Chapter 11 Northeast China Point-of-Care Diagnostics for Diabetes Market Analysis

    • 11.1 Northeast China Point-of-Care Diagnostics for Diabetes Market, by Type

    • 11.2 Northeast China Point-of-Care Diagnostics for Diabetes Market, by Application

    Chapter 12 Southwest China Point-of-Care Diagnostics for Diabetes Market Analysis

    • 12.1 Southwest China Point-of-Care Diagnostics for Diabetes Market, by Type

    • 12.2 Southwest China Point-of-Care Diagnostics for Diabetes Market, by Application

    Chapter 13 Northwest China Point-of-Care Diagnostics for Diabetes Market Analysis

    • 13.1 Northwest China Point-of-Care Diagnostics for Diabetes Market, by Type

    • 13.2 Northwest China Point-of-Care Diagnostics for Diabetes Market, by Application

    Chapter 14 Company Profiles

      • 14.1 ACON Laboratories

        • 14.1.1 ACON Laboratories Company Profile

        • 14.1.2 ACON Laboratories Point-of-Care Diagnostics for Diabetes Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Nova Biomedical

        • 14.2.1 Nova Biomedical Company Profile

        • 14.2.2 Nova Biomedical Point-of-Care Diagnostics for Diabetes Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 EKF Diagnostics

        • 14.3.1 EKF Diagnostics Company Profile

        • 14.3.2 EKF Diagnostics Point-of-Care Diagnostics for Diabetes Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Nipro

        • 14.4.1 Nipro Company Profile

        • 14.4.2 Nipro Point-of-Care Diagnostics for Diabetes Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Abbott

        • 14.5.1 Abbott Company Profile

        • 14.5.2 Abbott Point-of-Care Diagnostics for Diabetes Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Prodigy Diabetes Care, LLC

        • 14.6.1 Prodigy Diabetes Care, LLC Company Profile

        • 14.6.2 Prodigy Diabetes Care, LLC Point-of-Care Diagnostics for Diabetes Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 F Hoffmann-La Roche Ltd

        • 14.7.1 F Hoffmann-La Roche Ltd Company Profile

        • 14.7.2 F Hoffmann-La Roche Ltd Point-of-Care Diagnostics for Diabetes Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 PlatInium Equity Advisors, LLC (Lifescan, Inc)

        • 14.8.1 PlatInium Equity Advisors, LLC (Lifescan, Inc) Company Profile

        • 14.8.2 PlatInium Equity Advisors, LLC (Lifescan, Inc) Point-of-Care Diagnostics for Diabetes Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Bayer AG/Ascensia Diabetes Care Holdings AG

        • 14.9.1 Bayer AG/Ascensia Diabetes Care Holdings AG Company Profile

        • 14.9.2 Bayer AG/Ascensia Diabetes Care Holdings AG Point-of-Care Diagnostics for Diabetes Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Point-of-Care Diagnostics for Diabetes Industry Research Conclusions

    • 15.2 Point-of-Care Diagnostics for Diabetes Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Point-of-Care Diagnostics for Diabetes Industry Market Size (2018-2029)

    • Figure China Point-of-Care Diagnostics for Diabetes Production Volume, Production Value and Growth Rate of Type 2 Diabetes (2018-2029)

    • Figure China Point-of-Care Diagnostics for Diabetes Production Volume, Production Value and Growth Rate of Gestational Diabetes (2018-2029)

    • Figure China Point-of-Care Diagnostics for Diabetes Production Volume, Production Value and Growth Rate of Type 1 Diabetes (2018-2029)

    • Figure China Point-of-Care Diagnostics for Diabetes Sales Volume, Sales Value and Growth Rate of Hospitals and Diagnostic Laboratories (2018-2029)

    • Figure China Point-of-Care Diagnostics for Diabetes Sales Volume, Sales Value and Growth Rate of Homecare (2018-2029)

    • Figure China Point-of-Care Diagnostics for Diabetes Sales Volume, Sales Value and Growth Rate of Academic and Research Centers (2018-2029)

    • Figure North China Point-of-Care Diagnostics for Diabetes Market Size and Growth Rate from 2018-2029

    • Figure Central China Point-of-Care Diagnostics for Diabetes Market Size and Growth Rate from 2018-2029

    • Figure South China Point-of-Care Diagnostics for Diabetes Market Size and Growth Rate from 2018-2029

    • Figure East China Point-of-Care Diagnostics for Diabetes Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Point-of-Care Diagnostics for Diabetes Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Point-of-Care Diagnostics for Diabetes Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Point-of-Care Diagnostics for Diabetes Market Size and Growth Rate from 2018-2029

    • Figure Point-of-Care Diagnostics for Diabetes Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Point-of-Care Diagnostics for Diabetes Market Share by Type in 2018

    • Figure China Point-of-Care Diagnostics for Diabetes Market Share by Type in 2023

    • Figure China Point-of-Care Diagnostics for Diabetes Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Point-of-Care Diagnostics for Diabetes Production Volume and Growth Rate of Type 2 Diabetes (2018-2023)

    • Figure China Point-of-Care Diagnostics for Diabetes Production Volume and Growth Rate of Gestational Diabetes (2018-2023)

    • Figure China Point-of-Care Diagnostics for Diabetes Production Volume and Growth Rate of Type 1 Diabetes (2018-2023)

    • Figure China Point-of-Care Diagnostics for Diabetes Market Share by Application in 2018

    • Figure China Point-of-Care Diagnostics for Diabetes Market Share by Application in 2023

    • Figure China Point-of-Care Diagnostics for Diabetes Total Market Size and Growth Rate from Consumption End

    • Figure China Point-of-Care Diagnostics for Diabetes Market Size and Growth Rate of Hospitals and Diagnostic Laboratories (2018-2023)

    • Figure China Point-of-Care Diagnostics for Diabetes Market Size and Growth Rate of Homecare (2018-2023)

    • Figure China Point-of-Care Diagnostics for Diabetes Market Size and Growth Rate of Academic and Research Centers (2018-2023)

    • Table China Point-of-Care Diagnostics for Diabetes Production Volume by Region (2018-2023)

    • Table China Point-of-Care Diagnostics for Diabetes Production Volume Share by Region (2018-2023)

    • Figure China Point-of-Care Diagnostics for Diabetes Production Volume Share by Region (2018-2023)

    • Table China Point-of-Care Diagnostics for Diabetes Production Value by Region (2018-2023)

    • Table China Point-of-Care Diagnostics for Diabetes Production Value Share by Region (2018-2023)

    • Figure China Point-of-Care Diagnostics for Diabetes Production Value Share by Region (2018-2023)

    • Table China Point-of-Care Diagnostics for Diabetes Sales Volume by Region (2018-2023)

    • Table China Point-of-Care Diagnostics for Diabetes Sales Volume Share by Region (2018-2023)

    • Figure China Point-of-Care Diagnostics for Diabetes Sales Volume Share by Region (2018-2023)

    • Table China Point-of-Care Diagnostics for Diabetes Sales Value by Region (2018-2023)

    • Table China Point-of-Care Diagnostics for Diabetes Sales Value Share by Region (2018-2023)

    • Figure China Point-of-Care Diagnostics for Diabetes Sales Value Share by Region (2018-2023)

    • Table North China Point-of-Care Diagnostics for Diabetes Production Volume by Type (2018-2023)

    • Table North China Point-of-Care Diagnostics for Diabetes Production Volume Share by Type (2018-2023)

    • Figure North China Point-of-Care Diagnostics for Diabetes Production Volume Share by Type (2018-2023)

    • Table North China Point-of-Care Diagnostics for Diabetes Sales Volume by Application (2018-2023)

    • Table North China Point-of-Care Diagnostics for Diabetes Sales Volume Share by Application (2018-2023)

    • Figure North China Point-of-Care Diagnostics for Diabetes Sales Volume Share by Application (2018-2023)

    • Table Central China Point-of-Care Diagnostics for Diabetes Production Volume by Type (2018-2023)

    • Table Central China Point-of-Care Diagnostics for Diabetes Production Volume Share by Type (2018-2023)

    • Figure Central China Point-of-Care Diagnostics for Diabetes Production Volume Share by Type (2018-2023)

    • Table Central China Point-of-Care Diagnostics for Diabetes Sales Volume by Application (2018-2023)

    • Table Central China Point-of-Care Diagnostics for Diabetes Sales Volume Share by Application (2018-2023)

    • Figure Central China Point-of-Care Diagnostics for Diabetes Sales Volume Share by Application (2018-2023)

    • Table South China Point-of-Care Diagnostics for Diabetes Production Volume by Type (2018-2023)

    • Table South China Point-of-Care Diagnostics for Diabetes Production Volume Share by Type (2018-2023)

    • Figure South China Point-of-Care Diagnostics for Diabetes Production Volume Share by Type (2018-2023)

    • Table South China Point-of-Care Diagnostics for Diabetes Sales Volume by Application (2018-2023)

    • Table South China Point-of-Care Diagnostics for Diabetes Sales Volume Share by Application (2018-2023)

    • Figure South China Point-of-Care Diagnostics for Diabetes Sales Volume Share by Application (2018-2023)

    • Table East China Point-of-Care Diagnostics for Diabetes Production Volume by Type (2018-2023)

    • Table East China Point-of-Care Diagnostics for Diabetes Production Volume Share by Type (2018-2023)

    • Figure East China Point-of-Care Diagnostics for Diabetes Production Volume Share by Type (2018-2023)

    • Table East China Point-of-Care Diagnostics for Diabetes Sales Volume by Application (2018-2023)

    • Table East China Point-of-Care Diagnostics for Diabetes Sales Volume Share by Application (2018-2023)

    • Figure East China Point-of-Care Diagnostics for Diabetes Sales Volume Share by Application (2018-2023)

    • Table Northeast China Point-of-Care Diagnostics for Diabetes Production Volume by Type (2018-2023)

    • Table Northeast China Point-of-Care Diagnostics for Diabetes Production Volume Share by Type (2018-2023)

    • Figure Northeast China Point-of-Care Diagnostics for Diabetes Production Volume Share by Type (2018-2023)

    • Table Northeast China Point-of-Care Diagnostics for Diabetes Sales Volume by Application (2018-2023)

    • Table Northeast China Point-of-Care Diagnostics for Diabetes Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Point-of-Care Diagnostics for Diabetes Sales Volume Share by Application (2018-2023)

    • Table Southwest China Point-of-Care Diagnostics for Diabetes Production Volume by Type (2018-2023)

    • Table Southwest China Point-of-Care Diagnostics for Diabetes Production Volume Share by Type (2018-2023)

    • Figure Southwest China Point-of-Care Diagnostics for Diabetes Production Volume Share by Type (2018-2023)

    • Table Southwest China Point-of-Care Diagnostics for Diabetes Sales Volume by Application (2018-2023)

    • Table Southwest China Point-of-Care Diagnostics for Diabetes Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Point-of-Care Diagnostics for Diabetes Sales Volume Share by Application (2018-2023)

    • Table Northwest China Point-of-Care Diagnostics for Diabetes Production Volume by Type (2018-2023)

    • Table Northwest China Point-of-Care Diagnostics for Diabetes Production Volume Share by Type (2018-2023)

    • Figure Northwest China Point-of-Care Diagnostics for Diabetes Production Volume Share by Type (2018-2023)

    • Table Northwest China Point-of-Care Diagnostics for Diabetes Sales Volume by Application (2018-2023)

    • Table Northwest China Point-of-Care Diagnostics for Diabetes Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Point-of-Care Diagnostics for Diabetes Sales Volume Share by Application (2018-2023)

    • Table ACON Laboratories Company Profile

    • Table ACON Laboratories Point-of-Care Diagnostics for Diabetes Revenue, Price and Gross (2018-2023)

    • Table Nova Biomedical Company Profile

    • Table Nova Biomedical Point-of-Care Diagnostics for Diabetes Revenue, Price and Gross (2018-2023)

    • Table EKF Diagnostics Company Profile

    • Table EKF Diagnostics Point-of-Care Diagnostics for Diabetes Revenue, Price and Gross (2018-2023)

    • Table Nipro Company Profile

    • Table Nipro Point-of-Care Diagnostics for Diabetes Revenue, Price and Gross (2018-2023)

    • Table Abbott Company Profile

    • Table Abbott Point-of-Care Diagnostics for Diabetes Revenue, Price and Gross (2018-2023)

    • Table Prodigy Diabetes Care, LLC Company Profile

    • Table Prodigy Diabetes Care, LLC Point-of-Care Diagnostics for Diabetes Revenue, Price and Gross (2018-2023)

    • Table F Hoffmann-La Roche Ltd Company Profile

    • Table F Hoffmann-La Roche Ltd Point-of-Care Diagnostics for Diabetes Revenue, Price and Gross (2018-2023)

    • Table PlatInium Equity Advisors, LLC (Lifescan, Inc) Company Profile

    • Table PlatInium Equity Advisors, LLC (Lifescan, Inc) Point-of-Care Diagnostics for Diabetes Revenue, Price and Gross (2018-2023)

    • Table Bayer AG/Ascensia Diabetes Care Holdings AG Company Profile

    • Table Bayer AG/Ascensia Diabetes Care Holdings AG Point-of-Care Diagnostics for Diabetes Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.